• 1
    Pedersen KE, Elwood M. Current international developments in population screening for colorectal cancer. Aust N Z J Surg. 2002; 72: 507512.
  • 2
    National Center for Chronic Disease Prevention and Health Promotion. Behavioral risk factor surveillance system [database online]. Available from URL:[accessed Nov 11, 2003].
  • 3
    Cuzick J, Sasieni P. Cervical screening in the United Kingdom. Hong Kong Med J. 1999; 5: 269271.
  • 4
    Austoker J. Cancer prevention in primary care. Screening for cervical cancer. BMJ. 1994; 309: 241248.
  • 5
    Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst. 1999; 91: 16411646.
  • 6
    Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European Union. Eur J Cancer. 2000; 36: 14731478.
  • 7
    Calman K. Developing screening in the NHS. J Med Screen. 1994; 2: 101105.
  • 8
    Gray JA. Evidence-based screening in the United Kingdom. Int J Technol Assess Health Care. 2001; 17: 400408.
  • 9
    Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA. 2003; 290: 21292137.
  • 10
    Torgerson DJ, Donaldson C. An economic view of high compliance as a screening objective. BMJ. 1994; 308: 117119.
  • 11
    VainioH, BianchiniF, editors. IARC handbooks of cancer prevention. Volume 7: Breast cancer screening. Lyon: IARC Press, 2002.
  • 12
    Watt S. [The cost of screening for breast and cervical cancer in France]. Bull Cancer. 2003; 90: 9971004.
  • 13
    Breast Screening Frequency Trial Group. The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research. Eur J Cancer. 2002; 38: 14581464.
  • 14
    Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer. 2003; 89: 8893.
  • 15
    Sirovich BE, Welch HG. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004; 19: 243250.
  • 16
    Giles GG, Amos A. Evaluation of the organised mammographic screening programme in Australia. Ann Oncol. 2003; 14: 12091211.
  • 17
    Idestrom M, Milsom I, Andersson-Ellstrom A. Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years. Acta Obstet Gynecol Scand. 2002; 81: 962967.
  • 18
    Sin JP, St. Leger AS. Interventions to increase breast screening uptake: do they make any difference? J Med Screen. 1999; 6: 170181.
  • 19
    McGahan CE, Blanks RG, Moss SM. Reasons for variation in coverage in the NHS cervical screening programme. Cytopathology. 2001; 12: 354366.
  • 20
    Millett C, Bardsley M, Binysh K. Exploring the effects of population mobility on cervical screening coverage. Public Health. 2002; 116: 353360.
  • 21
    Australian Institute of Health and Welfare. BreastScreen Australia achievement report 1997 and 1998 [monograph online]. Available from URL:[accessed Nov 11, 2003].
  • 22
    NSW Cervical Screening Program and the NSW Pap Test Register. Annual statistical report 2001. Westmead Hospital, Sydney, 2002. Available from URL:[accessed April 2004].
  • 23
    Cockburn J, Sutherland M, Cappiello M, Hevern M. Predictors of attendance at a relocatable mammography service for rural women. Aust N Z J Public Health. 1997; 21: 739742.
  • 24
    Shelley JM, Irwig LM, Simpson JM, Macaskill P. Who has Pap smears in New South Wales? Patterns of screening across sociodemographic groups. Aust J Public Health. 1994; 18: 406411.
  • 25
    Stark CR, Reay L, Shiroyama C. The effect of access factors on breast screening attendance on two Scottish islands. Health Bull (Edinb). 1997; 55: 316321.
  • 26
    Straton JA, Holman CD, Edwards BM. Cervical cancer screening in Western Australia in 1992: progress since 1983. Med J Aust. 1993; 159: 657661.
  • 27
    Wain G, Morrell S, Taylor R, Mamoon H, Bodkin N. Variation in cervical cancer screening by region, socio-economic, migrant and indigenous status in women in New South Wales. Aust N Z J Obstet Gynaecol. 2001; 41: 320325.
  • 28
    NHS Breast Screening Programme. Report of the UKCCCR/NHSBSP Workshop. Breast screening acceptability: research and practice. NHSBSP Publication No. 28. 2003
  • 29
    Kee F, Telford AM, Donaghy P, O'Doherty A. Attitude or access: reasons for not attending mammography in Northern Ireland. Eur J Cancer Prev. 1992; 1: 311315.
  • 30
    Schofield PE, Cockburn J, Hill DJ, Reading D. Encouraging attendance at a screening mammography programme: determinants of response to different recruitment strategies. J Med Screen. 1994; 1: 144149.
  • 31
    Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Community Health. 1994; 48: 6573.
  • 32
    Sutton S, Wardle J, Taylor T, et al. Predictors of attendance in the United Kingdom Flexible Sigmoidoscopy Screening Trial. J Med Screen. 2000; 7: 99104.
  • 33
    King J, Fairbrother G, Thompson C, Morris DL. Colorectal cancer screening: optimal compliance with postal faecal occult blood test. Aust N Z J Surg. 1992; 62: 714719.
  • 34
    Stead MJ, Wallis MG, Wheaton ME. Improving uptake in non-attenders of breast screening: selective use of second appointment. J Med Screen. 1998; 5: 6972.
  • 35
    Turner KM, Wilson BJ, Gilbert FJ. Improving breast screening uptake: persuading initial non-attenders to attend. J Med Screen. 1994; 1: 199202.
  • 36
    Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13: 346354.
  • 37
    Banks E, Beral V, Cameron R, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 2002; 4: R1.
  • 38
    Lagerlund M, Widmark C, Lambe M, Tishelman C. Rationales for attending or not attending mammography screening—a focus group study among women in Sweden. Eur J Cancer Prev. 2001; 10: 429442.
  • 39
    Matson S, Andersson I, Berglund G, Janzon L, Manjer J. Nonattendance in mammographic screening: a study of intraurban differences in Malmo, Sweden, 1990-1994. Cancer Detect Prev. 2001; 25: 132137.
  • 40
    Government Statistical Service. Cervical screening programme, England: 2001–02 [monograph online]. Available from URL:[accessed Mar 25, 2004].
  • 41
    Challier B, Meslans Y, Viel JF. Deprived areas and attendance to screening of cervix uteri cancer in a French region. Cancer Causes Control. 2000; 11: 157162.
  • 42
    Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med. 2001; 32: 482491.
  • 43
    Eaker S, Adami HO, Sparen P. Attitudes to screening for cervical cancer: a population-based study in Sweden. Cancer Causes Control. 2001; 12: 519528.
  • 44
    UK CRC Screening Pilot Evaluation Team. Evaluation of the UK Colorectal Cancer Screening Pilot [monograph online]. Available from URL:[accessed Mar 25, 2004].
  • 45
    McCaffery K, Wardle J, Nadel M, Atkin W. Socioeconomic variation in participation in colorectal cancer screening. J Med Screen. 2002; 9: 104108.
  • 46
    Neilson AR, Whynes DK. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med. 1995; 41: 365374.
  • 47
    Weller D, Thomas D, Hiller J, Woodward A, Edwards J. Screening for colorectal cancer using an immunochemical test for faecal occult blood: results of the first 2 years of a South Australian programme. Aust N Z J Surg. 1994; 64: 464469.
  • 48
    Herbert C, Launoy G, Gignoux M. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation. Eur J Cancer Prev. 1997; 6: 4452.
  • 49
    Hoare T. Breast screening and ethnic minorities. Br J Cancer Suppl. 1996; 29: S38S41.
  • 50
    Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening—a population-based register study (Sweden). Cancer Causes Control. 2002; 13: 7382.
  • 51
    BreastScreen South Australia. 1998 statistical report. Wayville, Australia: BreastScreen South Australia, 2001.
  • 52
    BreastScreen Victoria. Annual statistical report, 2000. Carlton South, Australia: BreastScreen Victoria, 2001.
  • 53
    BreastScreen Queensland. Queensland health, 2003 [monograph online]. Available from URL: [accessed Nov 11, 2003].
  • 54
    O'Byrne AM, Kavanagh AM, Ugoni A, Diver F. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme. J Med Screen. 2000; 7: 190194.
  • 55
    Clarke V, Jones T. Evaluation of the cervical screening program. Melbourne: Centre for Behavioural Research in Cancer, 1997.
  • 56
    Siahpush M, Singh GK. Sociodemographic predictors of pap test receipt, currency and knowledge among Australian women. Prev Med 2002; 35: 363368.
  • 57
    Taylor RJ, Mamoon HA, Morrell SL, Wain GV. Cervical screening in migrants to Australia. Aust N Z J Public Health. 2001; 25: 5561.
  • 58
    Coory MD, Fagan PS, Muller JM, Dunn NA. Participation in cervical cancer screening by women in rural and remote Aboriginal and Torres Strait Islander communities in Queensland. Med J Aust. 2002; 177: 544547.
  • 59
    Speedy S, Hase S. Health beliefs and perceptions of women presenting or not presenting for mammographic screening in a rural health setting. Aust J Rural Health. 2000; 8: 208213.
  • 60
    Marteau TM, Hankins M, Collins B. Perceptions of risk of cervical cancer and attitudes towards cervical screening: a comparison of smokers and non-smokers. Fam Pract. 2002; 19: 1822.
  • 61
    Fylan F. Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour. Br J Gen Pract. 1998; 48: 15091514.
  • 62
    Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage? J R Soc Med. 1995; 88: 389394.
  • 63
    Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J. Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Aust N Z J Public Health. 2002; 26: 236241.
  • 64
    Frew E, Wolstenholme JL, Whynes DK. Willingness-to-pay for colorectal cancer screening. Eur J Cancer. 2001; 37: 17461751.
  • 65
    Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med. 2000; 31: 323334.
  • 66
    Cockburn J, White VM, Hirst S, Hill D. Barriers to cervical screening in older women. Aust Fam Physician. 1992; 21: 973978.
  • 67
    Crombie IK, Orbell S, Johnston G, Robertson AJ, Kenicer M. Women's experiences at cervical screening. Scott Med J. 1995; 40: 8182.
  • 68
    Wilson JR, Fazey JA. Self-esteem, compliance, and cervical screening. Psychol Rep. 1995; 77: 891898.
  • 69
    Yu CK, Rymer J. Women's attitudes to and awareness of smear testing and cervical cancer. Br J Fam Plann. 1998; 23: 127133.
  • 70
    McKie L. Women's views of the cervical smear test: implications for nursing practice—women who have had a smear test. J Adv Nurs. 1993; 18: 12281234.
  • 71
    Neilson A, Jones RK. Women's lay knowledge of cervical cancer/cervical screening: accounting for non-attendance at cervical screening clinics. J Adv Nurs. 1998; 28: 571575.
  • 72
    Cockburn J, Schofield P, White V, Hill D, Russell I. Predictors of returning for second round screening at a population based mammographic screening programme in Melbourne, Australia. J Epidemiol Community Health. 1997; 51: 6266.
  • 73
    Rimer BK, Briss PA, Zeller PK, Chan E, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004; 101(5 Suppl ): xxxxxx.
  • 74
    UK National Screening Committee. Second report of the UK National Screening Committee [monograph online]. Available from URL: [accessed Mar 25, 2004].
  • 75
    Zapka JG, Taplin SH, Solberg LI, Manos MM. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev. 2003; 12: 413.
  • 76
    Olesen F. Detecting cervical cancer: the European experience. Hong Kong Med J. 1999; 5: 272274.
  • 77
    Hurley SF. Screening: the need for a population register. Med J Aust. 1990; 153: 310311.
  • 78
    Wait SH, Allemand HM. The French breast cancer screening programme. Epidemiological and economic results of the first round of screening. Eur J Public Health. 1996; 6: 4348.
  • 79
    Patnick J. Cervical cancer screening in England. Eur J Cancer. 2000; 36: 22052208.